PDB Short entry for 2OPS HEADER TRANSFERASE 30-JAN-07 2OPS TITLE CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN TITLE 2 COMPLEX WITH GW420867X. COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: P51 RT; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: P51; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HIV-1 M:B_HXB2R; SOURCE 3 ORGANISM_TAXID: 11706; SOURCE 4 STRAIN: HXB2 ISOLATE; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DG2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PKK233-2; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HIV-1 M:B_HXB2R; SOURCE 13 ORGANISM_TAXID: 11706; SOURCE 14 STRAIN: HXB2 ISOLATE; SOURCE 15 GENE: GAG-POL; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: DG2; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PKK233-2 KEYWDS HIV-1 REVERSE TRANSCRIPTASE, AIDS, NNRTI, GW420867X, DRUG RESISTANCE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.REN,C.E.NICHOLS,P.P.CHAMBERLAIN,K.L.WEAVER,S.A.SHORT,J.H.CHAN, AUTHOR 2 J.KLEIM,D.K.STAMMERS REVDAT 5 27-DEC-23 2OPS 1 REMARK REVDAT 4 20-OCT-21 2OPS 1 REMARK SEQADV LINK REVDAT 3 12-NOV-14 2OPS 1 HET HETATM HETNAM HETSYN REVDAT 3 2 1 LINK MODRES SEQRES VERSN REVDAT 2 24-FEB-09 2OPS 1 VERSN REVDAT 1 22-MAY-07 2OPS 0 JRNL AUTH J.REN,C.E.NICHOLS,P.P.CHAMBERLAIN,K.L.WEAVER,S.A.SHORT, JRNL AUTH 2 J.H.CHAN,J.P.KLEIM,D.K.STAMMERS JRNL TITL RELATIONSHIP OF POTENCY AND RESILIENCE TO DRUG RESISTANT JRNL TITL 2 MUTATIONS FOR GW420867X REVEALED BY CRYSTAL STRUCTURES OF JRNL TITL 3 INHIBITOR COMPLEXES FOR WILD-TYPE, LEU100ILE, LYS101GLU, AND JRNL TITL 4 TYR188CYS MUTANT HIV-1 REVERSE TRANSCRIPTASES. JRNL REF J.MED.CHEM. V. 50 2301 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17441703 JRNL DOI 10.1021/JM061117M REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2232885.680 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 49547 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.301 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2472 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4507 REMARK 3 BIN R VALUE (WORKING SET) : 0.3580 REMARK 3 BIN FREE R VALUE : 0.4300 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 238 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7747 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 151 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.86000 REMARK 3 B22 (A**2) : -10.12000 REMARK 3 B33 (A**2) : 16.98000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 30.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.51 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.970 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 6.700 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 9.670 ; 10.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 10.310; 8.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 13.920; 14.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 47.29 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OPS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041436. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.244 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49585 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.32700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 69.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 69.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 64 REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 SER A 68 REMARK 465 THR A 69 REMARK 465 TRP B 88 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 GLN B 91 REMARK 465 LEU B 92 REMARK 465 GLY B 93 REMARK 465 GLY B 213 REMARK 465 LEU B 214 REMARK 465 THR B 215 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 TYR B 232 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE B 440 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN B 175 N ASP B 177 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 N ALA A 355 OE1 GLU B 297 2555 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 20 59.90 -148.08 REMARK 500 PRO A 52 -106.68 -77.96 REMARK 500 GLU A 53 38.75 -73.12 REMARK 500 GLN A 85 174.86 -46.72 REMARK 500 GLU A 89 135.55 150.44 REMARK 500 GLN A 91 131.27 -10.90 REMARK 500 ASP A 121 108.21 -49.31 REMARK 500 PRO A 133 -167.03 -55.78 REMARK 500 ASN A 137 -33.33 -21.71 REMARK 500 THR A 139 149.45 -38.05 REMARK 500 LEU A 149 107.21 -59.73 REMARK 500 MET A 184 -127.19 52.63 REMARK 500 ASP A 185 56.61 -117.69 REMARK 500 MET A 230 71.45 43.79 REMARK 500 PRO A 236 3.85 -62.18 REMARK 500 PRO A 247 177.28 -48.49 REMARK 500 PRO A 321 7.46 -68.49 REMARK 500 PRO A 345 114.45 -35.39 REMARK 500 PHE A 346 11.18 81.79 REMARK 500 HIS A 361 122.75 175.20 REMARK 500 PRO A 412 175.97 -57.56 REMARK 500 HIS A 539 23.31 48.92 REMARK 500 PRO B 9 80.52 -68.14 REMARK 500 GLU B 44 4.60 -65.04 REMARK 500 LYS B 66 91.04 10.80 REMARK 500 ASP B 67 112.08 42.87 REMARK 500 SER B 68 118.69 -173.01 REMARK 500 THR B 69 28.81 -79.26 REMARK 500 ALA B 98 -29.68 -31.36 REMARK 500 ASP B 121 131.02 -38.87 REMARK 500 GLU B 169 -70.54 -37.18 REMARK 500 PRO B 170 -29.67 -39.26 REMARK 500 ARG B 172 -70.87 -56.20 REMARK 500 LYS B 173 16.61 -54.81 REMARK 500 PRO B 176 24.38 1.23 REMARK 500 MET B 184 -138.92 35.96 REMARK 500 PRO B 236 -1.49 -45.50 REMARK 500 LYS B 238 -31.35 -169.16 REMARK 500 THR B 240 -154.64 -172.56 REMARK 500 ASP B 250 -74.03 -56.97 REMARK 500 THR B 286 76.01 -102.85 REMARK 500 THR B 439 72.76 -167.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 1302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBQ A 999 DBREF 2OPS A 2 543 UNP P04585 POL_HV1H2 589 1130 DBREF 2OPS B 6 440 UNP P04585 POL_HV1H2 593 1027 SEQADV 2OPS CYS A 188 UNP P04585 TYR 775 ENGINEERED MUTATION SEQADV 2OPS CSD A 280 UNP P04585 CYS 867 MODIFIED RESIDUE SEQADV 2OPS CYS B 188 UNP P04585 TYR 775 ENGINEERED MUTATION SEQRES 1 A 542 ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS PRO SEQRES 2 A 542 GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU THR SEQRES 3 A 542 GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR GLU SEQRES 4 A 542 MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO GLU SEQRES 5 A 542 ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS LYS SEQRES 6 A 542 ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG GLU SEQRES 7 A 542 LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN LEU SEQRES 8 A 542 GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SER SEQRES 9 A 542 VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER VAL SEQRES 10 A 542 PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE THR SEQRES 11 A 542 ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG TYR SEQRES 12 A 542 GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER PRO SEQRES 13 A 542 ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU PRO SEQRES 14 A 542 PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN TYR SEQRES 15 A 542 MET ASP ASP LEU CYS VAL GLY SER ASP LEU GLU ILE GLY SEQRES 16 A 542 GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS LEU SEQRES 17 A 542 LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS GLN SEQRES 18 A 542 LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU HIS SEQRES 19 A 542 PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO GLU SEQRES 20 A 542 LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU VAL SEQRES 21 A 542 GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY ILE SEQRES 22 A 542 LYS VAL ARG GLN LEU CSD LYS LEU LEU ARG GLY THR LYS SEQRES 23 A 542 ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA GLU SEQRES 24 A 542 LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU PRO SEQRES 25 A 542 VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU ILE SEQRES 26 A 542 ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR TYR SEQRES 27 A 542 GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR GLY SEQRES 28 A 542 LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP VAL SEQRES 29 A 542 LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR GLU SEQRES 30 A 542 SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS LEU SEQRES 31 A 542 PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR GLU SEQRES 32 A 542 TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE VAL SEQRES 33 A 542 ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU GLU SEQRES 34 A 542 LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL ASP SEQRES 35 A 542 GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA GLY SEQRES 36 A 542 TYR VAL THR ASN ARG GLY ARG GLN LYS VAL VAL THR LEU SEQRES 37 A 542 THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA ILE SEQRES 38 A 542 TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN ILE SEQRES 39 A 542 VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN ALA SEQRES 40 A 542 GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN ILE SEQRES 41 A 542 ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU ALA SEQRES 42 A 542 TRP VAL PRO ALA HIS LYS GLY ILE GLY SEQRES 1 B 435 GLU THR VAL PRO VAL LYS LEU LYS PRO GLY MET ASP GLY SEQRES 2 B 435 PRO LYS VAL LYS GLN TRP PRO LEU THR GLU GLU LYS ILE SEQRES 3 B 435 LYS ALA LEU VAL GLU ILE CYS THR GLU MET GLU LYS GLU SEQRES 4 B 435 GLY LYS ILE SER LYS ILE GLY PRO GLU ASN PRO TYR ASN SEQRES 5 B 435 THR PRO VAL PHE ALA ILE LYS LYS LYS ASP SER THR LYS SEQRES 6 B 435 TRP ARG LYS LEU VAL ASP PHE ARG GLU LEU ASN LYS ARG SEQRES 7 B 435 THR GLN ASP PHE TRP GLU VAL GLN LEU GLY ILE PRO HIS SEQRES 8 B 435 PRO ALA GLY LEU LYS LYS LYS LYS SER VAL THR VAL LEU SEQRES 9 B 435 ASP VAL GLY ASP ALA TYR PHE SER VAL PRO LEU ASP GLU SEQRES 10 B 435 ASP PHE ARG LYS TYR THR ALA PHE THR ILE PRO SER ILE SEQRES 11 B 435 ASN ASN GLU THR PRO GLY ILE ARG TYR GLN TYR ASN VAL SEQRES 12 B 435 LEU PRO GLN GLY TRP LYS GLY SER PRO ALA ILE PHE GLN SEQRES 13 B 435 SER SER MET THR LYS ILE LEU GLU PRO PHE ARG LYS GLN SEQRES 14 B 435 ASN PRO ASP ILE VAL ILE TYR GLN TYR MET ASP ASP LEU SEQRES 15 B 435 CYS VAL GLY SER ASP LEU GLU ILE GLY GLN HIS ARG THR SEQRES 16 B 435 LYS ILE GLU GLU LEU ARG GLN HIS LEU LEU ARG TRP GLY SEQRES 17 B 435 LEU THR THR PRO ASP LYS LYS HIS GLN LYS GLU PRO PRO SEQRES 18 B 435 PHE LEU TRP MET GLY TYR GLU LEU HIS PRO ASP LYS TRP SEQRES 19 B 435 THR VAL GLN PRO ILE VAL LEU PRO GLU LYS ASP SER TRP SEQRES 20 B 435 THR VAL ASN ASP ILE GLN LYS LEU VAL GLY LYS LEU ASN SEQRES 21 B 435 TRP ALA SER GLN ILE TYR PRO GLY ILE LYS VAL ARG GLN SEQRES 22 B 435 LEU CYS LYS LEU LEU ARG GLY THR LYS ALA LEU THR GLU SEQRES 23 B 435 VAL ILE PRO LEU THR GLU GLU ALA GLU LEU GLU LEU ALA SEQRES 24 B 435 GLU ASN ARG GLU ILE LEU LYS GLU PRO VAL HIS GLY VAL SEQRES 25 B 435 TYR TYR ASP PRO SER LYS ASP LEU ILE ALA GLU ILE GLN SEQRES 26 B 435 LYS GLN GLY GLN GLY GLN TRP THR TYR GLN ILE TYR GLN SEQRES 27 B 435 GLU PRO PHE LYS ASN LEU LYS THR GLY LYS TYR ALA ARG SEQRES 28 B 435 MET ARG GLY ALA HIS THR ASN ASP VAL LYS GLN LEU THR SEQRES 29 B 435 GLU ALA VAL GLN LYS ILE THR THR GLU SER ILE VAL ILE SEQRES 30 B 435 TRP GLY LYS THR PRO LYS PHE LYS LEU PRO ILE GLN LYS SEQRES 31 B 435 GLU THR TRP GLU THR TRP TRP THR GLU TYR TRP GLN ALA SEQRES 32 B 435 THR TRP ILE PRO GLU TRP GLU PHE VAL ASN THR PRO PRO SEQRES 33 B 435 LEU VAL LYS LEU TRP TYR GLN LEU GLU LYS GLU PRO ILE SEQRES 34 B 435 VAL GLY ALA GLU THR PHE MODRES 2OPS CSD A 280 CYS 3-SULFINOALANINE HET CSD A 280 8 HET PO4 A1301 5 HET HBQ A 999 20 HET PO4 B1302 5 HETNAM CSD 3-SULFINOALANINE HETNAM PO4 PHOSPHATE ION HETNAM HBQ ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4- HETNAM 2 HBQ DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 3 PO4 2(O4 P 3-) FORMUL 4 HBQ C14 H17 F N2 O3 FORMUL 6 HOH *151(H2 O) HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 GLY A 112 VAL A 118 5 7 HELIX 5 5 ASP A 121 ALA A 129 5 9 HELIX 6 6 GLY A 155 ASN A 175 1 21 HELIX 7 7 GLU A 194 ARG A 211 1 18 HELIX 8 8 THR A 253 SER A 268 1 16 HELIX 9 9 VAL A 276 LEU A 282 1 7 HELIX 10 10 THR A 296 LEU A 310 1 15 HELIX 11 11 ASN A 363 GLY A 384 1 22 HELIX 12 12 GLN A 394 TYR A 405 1 12 HELIX 13 13 THR A 473 SER A 489 1 17 HELIX 14 14 SER A 499 GLN A 509 1 11 HELIX 15 15 SER A 515 LYS A 528 1 14 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 ILE A 63 0 SHEET 2 B 2 ARG A 72 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 ILE A 178 TYR A 183 -1 N VAL A 179 O GLY A 190 SHEET 1 D 4 PHE A 227 TRP A 229 0 SHEET 2 D 4 TYR A 232 HIS A 235 -1 O TYR A 232 N TRP A 229 SHEET 3 D 4 LYS A 238 VAL A 241 -1 O LYS A 238 N HIS A 235 SHEET 4 D 4 HIS A 315 GLY A 316 -1 O GLY A 316 N TRP A 239 SHEET 1 E 5 LYS A 347 TYR A 354 0 SHEET 2 E 5 GLN A 336 GLU A 344 -1 N ILE A 341 O LEU A 349 SHEET 3 E 5 ILE A 326 GLY A 333 -1 N GLN A 330 O THR A 338 SHEET 4 E 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 E 5 TRP A 414 PHE A 416 1 O GLU A 415 N PHE A 389 SHEET 1 F 2 HIS A 361 THR A 362 0 SHEET 2 F 2 GLN A 512 SER A 513 -1 O GLN A 512 N THR A 362 SHEET 1 G 5 GLN A 464 THR A 470 0 SHEET 2 G 5 LEU A 452 THR A 459 -1 N GLY A 453 O LEU A 469 SHEET 3 G 5 GLU A 438 ALA A 446 -1 N ALA A 445 O LYS A 454 SHEET 4 G 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 G 5 LYS A 530 TRP A 535 1 O ALA A 534 N ILE A 495 LINK C LEU A 279 N CSD A 280 1555 1555 1.33 LINK C CSD A 280 N LYS A 281 1555 1555 1.34 CISPEP 1 PRO A 225 PRO A 226 0 -0.01 CISPEP 2 PRO A 420 PRO A 421 0 -0.29 SITE 1 AC1 3 GLY A 436 ASN A 460 ARG A 461 SITE 1 AC2 4 ARG B 356 ARG B 358 GLY B 359 HOH B1153 SITE 1 AC3 12 PRO A 95 LEU A 100 LYS A 101 LYS A 103 SITE 2 AC3 12 VAL A 179 TYR A 181 CYS A 188 GLY A 190 SITE 3 AC3 12 PHE A 227 TRP A 229 LEU A 234 TYR A 318 CRYST1 138.500 110.300 72.700 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007220 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013755 0.00000